Entresto 49 MG-51 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26F7WXT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,427
Award facts
- Contract value 100% obligated
- $41,427.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 29, 2026, to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency, provides for the supply of Entresto 49 mg-51 mg tablets (180-count) with a ceiling value of $41,427.13 and a completion date of January 30, 2026. The contract utilizes firm fixed-price pricing under a non-set-aside competitive procurement. Performance will be executed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle that extends through December 2026 and serves as the primary mechanism for supplying pharmaceutical products and medical commodities to military healthcare systems worldwide.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in comprehensive medical product delivery to Department of Defense and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. The DLA Troop Support Medical IDC enables the company to supply essential pharmaceutical commodities to military treatment facilities and other federal healthcare institutions, positioning Amerisourcebergen as a strategic supplier within the federal medical procurement landscape.
Quick answers
Who was awarded contract SPE2DR26F7WXT?
SPE2DR26F7WXT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F7WXT worth?
The government has obligated $41,427 on SPE2DR26F7WXT.
Is contract SPE2DR26F7WXT an order under another contract?
Yes. SPE2DR26F7WXT is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WXT competed?
The extent of competition for SPE2DR26F7WXT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award